NSEUpdates24 Aug 2026 · 24 Aug 2026, 11:56 am
Updates
Jagsonpal Pharmaceuticals Limited · JAGSNPHARM
✦ AI SummaryResults
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of 27950 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022'.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of 27950 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022 '.
Attachments (1)
📄pdf
Download →
JAGSNPHARM_24082026115551_ESOPAllotementIntimation27950.pdf
View document text
Corporate Office: Plot No. 412-415, Nimai Tower, 3rd Floor, Phase-IV, Udyog Vihar,
Sector-18, Gurugram -122015, Haryana (India)
Ph.: +91 124 4406710; E-mail: info@jagsonpal.com; Website: www.jagsonpal.com
CIN. : L74899DL1978PLC009181
August 24, 2026
The Department of Corporate Services- Listing The Department of Corporate Services- Listing
BSE Ltd, National Stock Exchange of India Ltd
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G,
Dalal Street, Mumbai-400 001 Bandra Kurla Complex, Bandra (E) Mumbai – 400
Scrip Code: 507789 051
Symbol: JAGSNPHARM
Subject: Allotment of Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option
Plan, 2022 (“JPL ESOP 2022”)
Dear Sir/ Madam,
Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we are
pleased to inform you that the Nomination and Remuneration Committee has issued and allotted 27,950 Equity
Shares of Rs. 2/- each under JPL ESOP 2022, to the eligible employees of the Company, upon exercise of vested
options. These shares shall rank Pari-passu with the existing equity shares of the Company, in all respects.
Consequent to the above allotment, the paid-up share capital of the Company has increased from Rs.
13,18,58,940 (constituting of 6,59,29,470 equity shares of Rs. 2/- each) to Rs. 13,19,14,840 (constituting of
6,59,57,420 equity shares of Rs. 2/- each).
Details under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, is
attached herewith.
We request you to take the above on record.
Thanking you,
For Jagsonpal Pharmaceuticals Limited
Pratham Rawal
Company Secretary & Compliance officer
Regd. Office: Innov8, 3rd Floor, Plot No. 211, Okhla Phase-3, New Delhi-110020 (India)
Mumbai Office: 13-14, Unit 3B, Phoenix Paragon Plaza, Kurla West, Mumbai, Maharashtra- 400070
Corporate Office: Plot No. 412-415, Nimai Tower, 3rd Floor, Phase-IV, Udyog Vihar,
Sector-18, Gurugram -122015, Haryana (India)
Ph.: +91 124 4406710; E-mail: info@jagsonpal.com; Website: www.jagsonpal.com
CIN. : L74899DL1978PLC009181
Details under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations,
2021
Sr. Particulars
1. Company name and address of Registered Office: Jagsonpal Pharmaceuticals Limited and
Registered Office- Innov8, 3rd Floor, Plot
No. 211, Okhla Phase-3, New Delhi- 110020
2. Name of the recognized Stock Exchanges on which BSE Limited and National Stock Exchange
the company's shares are listed: of India Limited
3. Filing date of the statement referred in Regulation July 26, 2022 - BSE
10(b) of the SEBI (Share Based Employee Benefits) July 27, 2022 - NSE
Regulations, 2021 with Stock Exchange:
4. Filing Number, if any: NA
5. Title of the Scheme pursuant to which shares are Jagsonpal Pharmaceuticals Limited
issued, if any: Employee Stock Option Plan, 2022
6. Kind of security to be listed: Equity Shares
7. Par value of the shares Rs. 2/-
8. Date of issue of shares August 24, 2026
9. Number of shares issued: 27,950
10. Share Certificate No., if applicable: NA
11. Distinctive number of the share, if applicable: 6,75,29,471 to 6,75,57,420
12. ISIN Number of the shares if issued in Demat: INE048B01035
13. Exercise price per share: Rs. 94.00/- for 6,800 Equity Shares
Rs. 113.60/- for 6,750 Equity Shares
Rs. 115.60/- for 14,400 Equity Shares
14. Premium per share: Rs. 92.00/- for 6,800 Equity Shares
Rs. 111/60/- for 6,750 Equity Shares
Rs. 113.60/- for 14,400 Equity Shares
15. Total Issued shares after this issue: 6,59,57,420
16. Total Issued share capital after this issue: Rs. 13,19,14,840
17. Details of any lock-in on the shares: NA
18. Date of expiry of lock-in: NA
19. Whether shares identical in all respects to existing Yes, the shares rank pari passu with the
shares if not, when will they become identical? existing shares
20. Details of listing fees, if payable: NA
For Jagsonpal Pharmaceuticals Limited
Pratham Rawal
Company Secretary & compliance officer
Regd. Office: Innov8, 3rd Floor, Plot No. 211, Okhla Phase-3, New Delhi-110020 (India)
Mumbai Office: 13-14, Unit 3B, Phoenix Paragon Plaza, Kurla West, Mumbai, Maharashtra- 400070